Ocular Therapeutix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Ocular Therapeutix 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About OCUL

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. 

CEO
Pravin U. Dugel
CEOPravin U. Dugel
Employees
325
Employees325
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2006
Founded2006
Employees
325
Employees325

OCUL Key Statistics

Market cap
1.53B
Market cap1.53B
Price-Earnings ratio
-4.93
Price-Earnings ratio-4.93
Dividend yield
—
Dividend yield—
Average volume
4.49M
Average volume4.49M
High today
$7.56
High today$7.56
Low today
$6.94
Low today$6.94
Open price
$7.42
Open price$7.42
Volume
4.96M
Volume4.96M
52 Week high
$16.44
52 Week high$16.44
52 Week low
$6.23
52 Week low$6.23

Stock Snapshot

Ocular Therapeutix(OCUL) stock is priced at $7.06, giving the company a market capitalization of 1.53B. It carries a P/E multiple of -4.93.

On 2026-10-03, Ocular Therapeutix(OCUL) stock traded between a low of $6.94 and a high of $7.56. Shares are currently priced at $7.06, which is +1.8% above the low and -6.6% below the high.

Ocular Therapeutix(OCUL) shares are trading with a volume of 4.96M, against a daily average of 4.49M.

During the past year, Ocular Therapeutix(OCUL) stock moved between $6.23 at its lowest and $16.44 at its peak.

During the past year, Ocular Therapeutix(OCUL) stock moved between $6.23 at its lowest and $16.44 at its peak.

OCUL News

Simply Wall St 1d
Can Ocular Therapeutix Justify Its Price On Sales? - Simply Wall Street

...

Can Ocular Therapeutix Justify Its Price On Sales? - Simply Wall Street

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OCUL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.